ClinicalTrials.Veeva

Menu

Transition From Adolescents to Adulthood for Patients With Congenital Heart Diseases

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Completed

Conditions

Congenital Heart Diseases

Treatments

Other: Therapeutic education
Other: Standard follow-up

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The Investigators aim to measure the impact of a transition program in congenital cardiology in terms of health-related quality of life.

Full description

The number of adults with congenital heart diseases (CHD) is increasing. However, many young adults are lost to follow-up even in experienced tertiary care centers. American and European guidelines recommend to improve the management of young adults with CHD. Structured therapeutic education programs are therefore needed to optimize the transfer to adult healthcare. Our tertiary care CHD center recently implemented a transition program and simultaneously investigators decided to measure its impact. Indeed investigators need data from randomized trials in this filed. After previous controlled quality of life studies among children and adults with CHD, investigators chose to use the health-related quality of life (HR-QoL) as primary endpoint in this randomized study to focus on patient related outcomes.

The investigators assume that patients who participate in this program will improve their quality of life compared to controls. If investigators demonstrate the benefit of this program, it will have important consequences for patients with CHD and eventually for patients with other chronic medical conditions.

Enrollment

200 patients

Sex

All

Ages

13 to 25 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient from 13 years to 25 years inclusive.
  • Carrying of Congenital Heart Disease as defined in the International Classification.
  • Possible follow-up for one year on one of the three hospital center.
  • Informed consent of the patient for adults and, parents or legal guardians for minors.
  • Affiliation to a social security system.

Exclusion criteria

  • Non-francophone,
  • Severe intellectual impairment.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

Therapeutic education
Experimental group
Description:
Structured therapeutic education programs
Treatment:
Other: Therapeutic education
Control group
Active Comparator group
Description:
standard outpatient follow-up
Treatment:
Other: Standard follow-up

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems